peptide-solutions
IGF-1 LR3
Long-acting IGF-1 analog for growth research
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.
IGF-1 LR3 is a recombinant analog of insulin-like growth factor 1 with a modified N-terminus that reduces binding protein interaction, extending its activity duration.
Compound Specifications
Scientific Documentation
Research Reference
Detailed research information, pharmacological profile, and handling specifications
Mechanism of Action
Binds IGF-1 receptors to stimulate protein synthesis, cell proliferation, and inhibit apoptosis. The LR3 modification reduces IGFBP binding by 2-3 fold, extending half-life from minutes to several hours.
Research Use Only Disclaimer
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Related Compounds
Other research peptides you may be interested in
HCG
Human chorionic gonadotropin for reproductive research
$55
TESAMORELIN 10MG
GHRH analog for metabolic and body composition research
$65
MOTS-C
Mitochondrial peptide for metabolic research
from $40